Science
Two Private Moon Landers Are Launching at Once: What to Know
A space twofer is scheduled to take place early Wednesday morning — two lunar missions for the price of one rocket launch.
A SpaceX Falcon 9 will lift off from the Cape Canaveral Space Force Station in Florida, carrying the Blue Ghost lander built by Firefly Aerospace of Austin, Texas, and the Resilience lander from Ispace of Japan.
When is the launch and how can I watch it?
The launch is scheduled for 1:11 a.m. Eastern time on Wednesday. Forecasts predict a 90 percent chance of favorable weather.
SpaceX will provide coverage of the launch on the social media platform X beginning about one hour before liftoff, or around 12:10 a.m. NASA will start a live video stream at 12:30 a.m. of Blue Ghost and the payloads it is carrying for the agency, which you can watch in the video player above. Ispace will provide coverage of its Resilience lander in English and Japanese starting at 12:20 a.m.
If needed, a backup launch time is available on Thursday at 1:09 a.m., although the weather is less favorable.
Why are two moon landers sharing one rocket?
That is the result of fortuitous scheduling by SpaceX and not something that was planned by Firefly or Ispace.
Firefly had purchased a Falcon 9 launch to send its Blue Ghost lander to the moon. At the same time, Ispace, to save on the costs for the mission, had asked SpaceX for a rideshare, that is, hitching a ride as a secondary payload on a rocket launch that was going roughly in the right direction to get its Resilience lander to the moon. That turned out to be Blue Ghost’s trip.
“It was a no-brainer to put them together,” Julianna Scheiman, the director for NASA science missions at SpaceX, said during a news conference on Tuesday.
After the Falcon 9 rocket reaches orbit, the second stage will fire again for a minute so that it can deploy Blue Ghost in an elliptical orbit around Earth about one hour after launch. Then the rocket stage will fire once more, for just one second, to adjust the orbit for the deployment of Resilience about 1.5 hours after launch.
What are Firefly and Blue Ghost?
Firefly Aerospace is one of the new space companies that have popped up over the past few years. It has developed and launched a small rocket called Alpha several times. In 2023 Firefly demonstrated that it could prepare and launch a payload for the United States Space Force within days — a capability that the Department of Defense is looking to develop so that it could quickly replace satellites that come under attack.
Blue Ghost — named after a species of fireflies — is a robotic lander that Firefly has developed to take scientific instruments and other payloads to the surface of the moon.
This mission is headed to Mare Crisium, a flat plain formed from lava that filled and hardened inside a 345-mile-wide crater carved out by an ancient asteroid impact. Mare Crisium is in the northeast quadrant of the near side of the moon.
NASA will pay Firefly $101.5 million if it takes 10 payloads to the lunar surface, and a bit less if it does not fully succeed. The NASA payloads include a drill to measure the flow of heat from the moon’s interior to the surface, an electrodynamic dust shield to clean off glass and radiator surfaces, and an X-ray camera.
The lander will operate for about 14 days — the length of a lunar day — until darkness descends at the landing site.
What are Ispace and Resilience?
This is Ispace’s second attempt to place a commercial lander on the surface of the moon. Its Hakuto-R Mission 1 lander tried to set down near the Atlas crater on the near side of the moon. But the landing software was confused when it passed over the crater rim, which is two miles higher than the surrounding terrain. The spacecraft ended up hovering far above the ground after thinking it had landed and then crashed when it ran out of propellant.
Resilience — also known as the Hakuto-R Mission 2 lander — is essentially the same design as the Mission 1 spacecraft, but with different payloads. Ispace officials said they were confident that the mistakes that led to the crash in 2023 had been fixed.
The payloads on Resilience include a water electrolyzer experiment, which splits the hydrogen and oxygen molecules, from the Takasago Thermal Engineering Company in Japan, and a small rover named Tenacious that was developed and built by Ispace’s European subsidiary.
Although this is not a NASA mission, it will collect two soil samples — one scooped up by the rover, the other just soil that settles on the landing pads — and sell them to the agency for $5,000 each.
The transactions have no scientific value, because the samples will remain on the moon. Instead, they are meant to help strengthen the view of the United States government that while no nation on Earth can claim sovereignty of the moon or other parts of the solar system under the Outer Space Treaty of 1967, nations and companies can own and profit from what they extract from the moon.
Resilience and Tenacious are also designed to operate for one lunar day, or 14 Earth days.
Which mission will arrive at the moon first?
Blue Ghost should get to the moon first on March 2. For the first 25 days, it is to circle around Earth as the company turns on and checks out the spacecraft’s systems, before heading on a four-day journey to the moon. Then it will orbit the moon for 16 days before trying to land, 45 days after launch.
Resilience will take a longer, winding path that consumes less energy and propellant, gradually stretching out its elliptical orbit until the farthest point of the orbit reaches beyond the moon. As a secondary payload on the Falcon 9, it will need to perform a flyby of the moon to get into the correct position to be captured into lunar orbit.
The vehicle is to land on a plain named Mare Frigoris about four to five months after launch.
Both Blue Ghost and Resilience might be beaten by a spacecraft from Intuitive Machines of Houston that is not scheduled to launch until late February. Despite its later start, it will take a direct, quicker path to the moon.
Intuitive Machines placed Odysseus, its first lander, on the moon in a trip sponsored by NASA last year. It was still successfully able to contact Earth despite tipping over.
Why are private companies landing on the moon?
By hiring private companies, NASA hopes to send more devices to the moon at a lower cost to perform experiments and test new technologies. A second aim of the Commercial Lunar Payload Services program, or C.L.P.S., is to jump-start a commercial industry there that would not otherwise develop.
NASA officials expect failures along the way, and that is what has happened. The first C.L.P.S. mission by Astrobotic Technology of Pittsburgh suffered a catastrophic propulsion failure soon after launch and never made it close to the moon. The tipping of the second Intuitive Machine lander during the second C.L.P.S. mission prevented the scientific instruments aboard from collecting the data they were sent to measure.
The American subsidiary of Ispace is collaborating with Draper Laboratory in Cambridge, Mass., for a C.L.P.S. mission that is scheduled to launch next year.
Science
Judge blocks Trump administration move to cut $600 million in HIV funding from states
A federal judge on Thursday blocked a Trump administration order slashing $600 million in federal grant funding for HIV programs in California and three other states, finding merit in the states’ argument that the move was politically motivated by disagreements over unrelated state sanctuary policies.
U.S. District Judge Manish Shah, an Obama appointee in Illinois, found that California, Colorado, Illinois and Minnesota were likely to succeed in arguing that President Trump and other administration officials targeted the U.S. Centers for Disease Control and Prevention funding for termination “based on arbitrary, capricious, or unconstitutional rationales.”
Namely, Shah wrote that while Trump administration officials said the programs were cut for breaking with CDC priorities, other “recent statements” by officials “plausibly suggest that the reason for the direction is hostility to what the federal government calls ‘sanctuary jurisdictions’ or ‘sanctuary cities.’”
Shah found that the states had shown they would “suffer irreparable harm” from the cuts, and that the public interest would not be harmed by temporarily halting them — and as a result granted the states a temporary restraining order halting the administration’s action for 14 days while the litigation continues.
Shah wrote that while he may not have jurisdiction to block a simple grant termination, he did have jurisdiction to halt an administration directive to terminate funding based on unconstitutional grounds.
“More factual development is necessary and it may be that the only government action at issue is termination of grants for which I have no jurisdiction to review,” Shah wrote. “But as discussed, plaintiffs have made a sufficient showing that defendants issued internal guidance to terminate public-health grants for unlawful reasons; that guidance is enjoined as the parties develop a record.”
The cuts targeted a slate of programs aimed at tracking and curtailing HIV and other disease outbreaks, including one of California’s main early-warning systems for HIV outbreaks, state and local officials said. Some were oriented toward serving the LGBTQ+ community. California Atty. Gen. Rob Bonta’s office said California faced “the largest share” of the cuts.
The White House said the cuts were to programs that “promote DEI and radical gender ideology,” while federal health officials said the programs in question did not reflect the CDC’s “priorities.”
Bonta cheered Shah’s order in a statement, saying he and his fellow attorneys general who sued are “confident that the facts and the law favor a permanent block of these reckless and illegal funding cuts.”
Science
Contributor: Is there a duty to save wild animals from natural suffering?
The internet occasionally erupts in horror at disturbing images of wildlife: deer with freakish black bubbles all over their faces and bodies, sore-ridden squirrels, horn-growing rabbits.
As a society, we tend to hold romanticized notions about life in the wild. We picture these rabbits nuzzling with their babies, these squirrels munching on some nuts and these deer frolicking through sunlit meadows. Yet the trend of Frankenstein creatures afflicted with various diseases is steadily peeling back this idyllic veneer, revealing the harsher realities that underpin the natural world. And we should do something about it.
First, consider that wild animals — the many trillions of them — aren’t so different from other animals we care about — like dogs and cats — or even from us. They love. They build complex social structures. They have emotions. And most important, they too experience suffering.
Many wild animals are suffering because of us. We destroy their habitats, they’re sterilized and killed by our pollution, and sometimes we hunt them down as trophies. Suffering created by humans is especially galling.
But even in the absence of human impact, wild animals still experience a great deal of pain. They starve and thirst. They get infected by parasites and diseases. They’re ripped apart by other animals. Some of us have bought into the naturalistic fallacy that interfering with nature is wrong. But suffering is suffering wherever it occurs, and we should do something about it when we can. If we have the opportunity to rescue an injured or ill animal, why wouldn’t we? If we can alleviate a being’s suffering, shouldn’t we?
If we accept that we do have an obligation to help wild animals, where should we start? Of course, if we have an obvious opportunity to help an animal, like a bird with a broken wing, we ought to step in, maybe take it to a wildlife rescue center if there are any nearby. We can use fewer toxic products and reduce our overall waste to minimize harmful pollution, keep fresh water outside on hot summer days, reduce our carbon footprint to prevent climate-change-induced fires, build shelter for wildlife such as bats and bees, and more. Even something as simple as cleaning bird feeders can help reduce rates of disease in wild animals.
And when we do interfere in nature in ways that affect wild animals, we should do so compassionately. For example, in my hometown of Staten Island, in an effort to combat the overpopulation of deer (due to their negative impact on humans), officials deployed a mass vasectomy program, rather than culling. And it worked. Why wouldn’t we opt for a strategy that doesn’t require us to put hundreds of innocent animals to death?
But nature is indifferent to suffering, and even if we do these worthy things, trillions will still suffer because the scale of the problem is so large — literally worldwide. It’s worth looking into the high-level changes we can make to reduce animal suffering. Perhaps we can invest in the development and dissemination of cell-cultivated meat — meat made from cells rather than slaughtered animals — to reduce the amount of predation in the wild. Gene-drive technology might be able to make wildlife less likely to spread diseases such as the one afflicting the rabbits, or malaria. More research is needed to understand the world around us and our effect on it, but the most ethical thing to do is to work toward helping wild animals in a systemic way.
The Franken-animals that go viral online may have captured our attention because they look like something from hell, but their story is a reminder that the suffering of wild animals is real — and it is everywhere. These diseases are just a few of the countless causes of pain in the lives of trillions of sentient beings, many of which we could help alleviate if we chose to. Helping wild animals is not only a moral opportunity, it is a responsibility, and it starts with seeing their suffering as something we can — and must — address.
Brian Kateman is co-founder of the Reducetarian Foundation, a nonprofit organization dedicated to reducing consumption of animal products. His latest book and documentary is “Meat Me Halfway.”
Insights
L.A. Times Insights delivers AI-generated analysis on Voices content to offer all points of view. Insights does not appear on any news articles.
Viewpoint
Perspectives
The following AI-generated content is powered by Perplexity. The Los Angeles Times editorial staff does not create or edit the content.
Ideas expressed in the piece
- Wild animals experience genuine suffering comparable to that of domesticated animals and humans, including through starvation, disease, parasitism, and predation, and society romanticizes wildlife in ways that obscure these harsh realities[1][2]
- Humans have a moral obligation to address wild animal suffering wherever possible, as suffering is morally significant regardless of whether it occurs naturally or results from human action[2]
- Direct intervention in individual cases is warranted, such as rescuing injured animals or providing fresh water during heat waves, alongside broader systemic approaches like reducing pollution and carbon emissions[2]
- Humane wildlife management strategies should be prioritized over lethal approaches when addressing human-wildlife conflicts, as demonstrated by vasectomy programs that manage overpopulation without mass culling[2]
- Large-scale technological solutions, including cell-cultivated meat to reduce predation and gene-drive technology to control disease transmission, should be pursued and researched to systematically reduce wild animal suffering at scale[2]
- The naturalistic fallacy—the belief that natural processes should never be interfered with—is fundamentally flawed when weighed against the moral imperative to alleviate suffering[2]
Different views on the topic
The search results provided do not contain explicit opposing viewpoints to the author’s argument regarding a moral duty to intervene in wild animal suffering. The available sources focus primarily on the author’s work on reducing farmed animal consumption through reducetarianism and factory farming advocacy[1][3][4], rather than perspectives that directly challenge the premise that humans should work to alleviate wild animal suffering through technological or ecological intervention.
Science
Contributor: Factory farming of fish is brewing pathogens
The federal government recently released new dietary guidelines aimed at “ending the war on protein” and steering Americans toward “real foods” — those with few ingredients and no additives. Seafood plays a starring role. But the fish that health advocates envision appearing on our plates probably won’t be caught in the crystal blue waters we’d like to imagine.
Over the past few decades, the seafood industry has completely revolutionized how it feeds the world. As many wild fish populations have plummeted, hunted to oblivion by commercial fleets, fish farming has become all the rage, and captive-breeding facilities have continually expanded to satiate humanity’s ravenous appetite. Today, the aquaculture sector is a $300-billion juggernaut, accounting for nearly 60% of aquatic animal products used for direct human consumption.
Proponents of aquaculture argue that it helps feed a growing human population, reduces pressure on wild fish populations, lowers costs for consumers and creates new jobs on land. Much of that may be correct. But there is a hidden crisis brewing beneath the surface: Many aquaculture facilities are breeding grounds for pathogens. They’re also a blind spot for public health authorities.
On dry land, factory farming of cows, pigs and chickens is widely reviled, and for good reason: The unsanitary and inhumane conditions inside these facilities contribute to outbreaks of disease, including some that can leap from animals to humans. In many countries, aquaculture facilities aren’t all that different. Most are situated in marine and coastal areas, where fish can be exposed to a sinister brew of human sewage, industrial waste and agricultural runoff. Fish are kept in close quarters — imagine hundreds of adult salmon stuffed into a backyard swimming pool — and inbreeding compromises immune strength. Thus, when one fish invariably falls ill, pathogens spread far and wide throughout the brood — and potentially to people.
Right now, there are only a handful of known pathogens — mostly bacteria, rather than viruses — that can jump from aquatic species to humans. Every year, these pathogens contribute to the 260,000 illnesses in the United States from contaminated fish; fortunately, these fish-borne illnesses aren’t particularly transmissible between people. It’s far more likely that the next pandemic will come from a bat or chicken than a rainbow trout. But that doesn’t put me at ease. The ocean is a vast, poorly understood and largely unmonitored reservoir of microbial species, most of which remain unknown to science. In the last 15 years, infectious diseases — including ones that we’ve known about for decades such as Ebola and Zika — have routinely caught humanity by surprise. We shouldn’t write off the risks of marine microbes too quickly.
My most immediate concern, the one that really makes me sweat, is the emergence of drug-resistant bacteria among farmed fish. Aquaculturists are well aware that their fish often live in a festering cesspool, and so many growers will mix antibiotics — including ones that the World Health Organization considers medically important for people — into fish feed, or dump them straight into water, to avoid the consequences of crowded conditions and prevent rampant illness. It would be more appropriate to use antibiotics in animals only when they are sick.
Because of this overuse for prevention purposes, more antibiotics are used in seafood raised by aquaculture than are used in humans or for other farmed animals per kilogram. Many of these molecules will end up settling in the water or nearby sediment, where they can linger for weeks. In turn, the 1 million individual bacteria found in every drop of seawater will be put to the evolutionary test, and the most antibiotic-resistant will endure.
Numerous researchers have found that drug-resistant strains of bacteria are alarmingly common in the water surrounding aquaculture facilities. In one study, evidence of antibiotic resistance was found in over 80% of species of bacteria isolated from shrimp sold in multiple countries by multiple brands.
Many drug-resistant strains in aquatic animals won’t be capable of infecting humans, but their genes still pose a threat through a process known as horizontal transfer. Bacteria are genetic hoarders. They collect DNA from their environment and store it away in their own genome. Sometimes, they’ll participate in swap meets, trading genes with other bacteria to expand their collections. Beginning in 1991, for example, a wave of cholera infected nearly a million people across Latin America, exacerbated by a strain that may have picked up drug-resistant adaptations while circulating through shrimp farms in Ecuador.
Today, drug-resistant bacteria kill over a million people every year, more than HIV/AIDS. I’ve seen this with my own eyes as a practicing tuberculosis doctor. I am deeply fearful of a future in which the global supply of fish — a major protein source for billions of people — also becomes a source of untreatable salmonella, campylobacter and vibrio. We need safer seafood, and the solutions are already at our fingertips.
Governments need to lead by cracking down on indiscriminate antibiotic use. It is estimated that 70% of all antibiotics used globally are given to farm animals, and usage could increase by nearly 30% over the next 15 years. Regulation to promote prudent use of antibiotics in animals, however, has proven effective in Europe, and sales of veterinary antibiotics decreased by more than 50% across 25 European countries from 2011 to 2022. In the United States, the use of medically important antibiotics in food animals — including aquatic ones — is already tightly regulated. Most seafood eaten in the U.S., however, is imported and therefore beyond the reach of these rules. Indeed, antibiotic-resistance genes have already been identified in seafood imported into the United States. Addressing this threat should be an area of shared interest between traditional public health voices and the “Make America Healthy Again” movement, which has expressed serious concerns about the health effects of toxins.
Public health institutions also need to build stronger surveillance infrastructure — for both disease and antibiotic use — in potential hotspots. Surveillance is the backbone of public health, because good decision-making is impossible without good data. Unfortunately, many countries — including resource-rich countries — don’t robustly track outbreaks of antibiotic-resistant pathogens in farmed animals, nor do they share data on antibiotic use in farmed animals. By developing early warning systems for detecting antibiotic resistance in aquatic environments, rapid response efforts involving ecologists, veterinarians and epidemiologists can be mobilized as threats arise to avert public health disasters.
Meanwhile, the aquaculture industry should continue to innovate. Genetic technologies and new vaccines can help prevent rampant infections, while also improving growth efficiency that could allow for more humane conditions.
For consumers, the best way to stay healthy is simple: Seek out antibiotic-free seafood at the supermarket, and cook your fish (sorry, sushi lovers).
There’s no doubt that aquaculture is critical for feeding a hungry planet. But it must be done responsibly.
Neil M. Vora is a practicing physician and the executive director of the Preventing Pandemics at the Source Coalition.
-
Politics1 week agoWhite House says murder rate plummeted to lowest level since 1900 under Trump administration
-
Alabama6 days agoGeneva’s Kiera Howell, 16, auditions for ‘American Idol’ season 24
-
San Francisco, CA1 week agoExclusive | Super Bowl 2026: Guide to the hottest events, concerts and parties happening in San Francisco
-
Ohio1 week agoOhio town launching treasure hunt for $10K worth of gold, jewelry
-
Culture1 week agoIs Emily Brontë’s ‘Wuthering Heights’ Actually the Greatest Love Story of All Time?
-
News1 week agoThe Long Goodbye: A California Couple Self-Deports to Mexico
-
Politics1 week agoTrump admin sued by New York, New Jersey over Hudson River tunnel funding freeze: ‘See you in court’
-
Science1 week agoTuberculosis outbreak reported at Catholic high school in Bay Area. Cases statewide are climbing